288
Participants
Start Date
October 31, 2007
Primary Completion Date
May 31, 2011
Study Completion Date
May 31, 2011
5-ASA (5-Aminosalicylate)
500 mg tablet (modified extended release)
5-ASA (5-Aminosalicylate)
500 mg tablet
University of Calgary, Faculty of Medicine, Calgary
Castledowns Medicentre, Edmonton
Investigational site, Brandon
Hilyard Place Building A, Saint John
Barrie GI Associates, Barrie
Investigational site, Greater Sudbury
Investigational site, Guelph
St. Joseph's Healthcare, Hamilton
Investigational site, Oshawa
Investigational site - Phenix Building, Ottawa
Ottawa General Hospital, Ottawa
Digestive Health Clinic, Richmond Hill
Investigational site, Sarnia
Investigational site, Thunder Bay
JJ Dig Research Ltd, Toronto
Keele Medical Place, Toronto
St. Michael's Hospital, Toronto
Toronto Digestive Disease Association (TDDA), Toronto
Hotel Dieu Grace Hospital, Windsor
Investigational site, Windsor
Investigational site, Woodstock
Hotel Dieu de Levis, Lévis
Alpha Recherche Clinique Inc., Loretteville
Hopital Maissonneuve Rosemont, Montreal
MUHC-Royal Victoria Hospital, Montreal
Gastro Centre Hospitalier Universitaire de Québec/St-François-d'Assise Hospital, Québec
L'Hotel Dieu de Quebec, Québec
Lead Sponsor
Ferring Pharmaceuticals
INDUSTRY